This work deals with the state of watercourses, the territorial system of ecological stabi-lity and the possibilities of improvement for a state close to nature. The Rohelnice river basin and the solved watercourses are located in the Olomouc Region in the Morava River Basin. HEM - Hydroecological monitoring is a part of the assessment of the state of watercourses, which is a requirement of the European Water Framework Directive. The work contains the elaboration of a literature search on this topic with a focus on water retention in the landscape and the possibility of improving ecological stability in the basin. The content of the diploma thesis is to evaluate the hydromorphological status of watercourses in the Rohelnice river basin with the selection of sections on watercourses and places in the wider river basin for elements of ecological stability on the basis of zoning plans of affected cities and municipalities and improvement of the overall ecological status in the Rohelnice river basin.

Bakgrund: Under 2015 ansökte 35 369 ensamkommande barn om asyl i Sverige, vilket var en kraftig ökning jämfört med tidigare och senare åren. Det fanns tidigare brister i socialtjänstens ansvarsutövning gentemot ensamkommande barnen även under normala omständigheter. Vi har undersökt om socialtjänsten kunde tillgodose barnens behov och rättigheter i enlighet med socialtjänstlagen och barnkonventionen efter att så många asylsökande barn anlände i Sverige i en kort tid år 2015. Syfte: Syftet med studien var att studera hur har socialsekreterarna inom socialtjänsten upplevt och utfört sin roll och ansvarsutövning angående ensamkommande barn som anlänt i Sverige år 2015 och senare. Vår frågeställning var: Hur har socialtjänstpersonalen utfört sin ansvarsutövning gällande integrationsprocess av ensamkommande barn som har kommit till Sverige 2015 och senare? Metod: Undersökningen gjordes genom kvalitativ metod med 20 semistrukturerade intervjufrågor som formulerades och ställdes till nio utvalda erfarna social/barnsekreterare i Göteborgsregionen. Intervjuerna genomfördes på distans antingen digitalt eller telefonledes på grund av rådande Corona pandemin och spelades in och sedan transkriberades. Resultat: Respondenterna upplevde situationen under flyktingvågen 2015 som ”stressig”, ”jättetuff”, ”kaotisk” och ”överbelastande” då varken kommuner eller samhället var förberedd för ett sådant stor inflödet av flyktingar. Konsekvensen blev då att ensamkommande barnens basala behov såsom socialhandläggare, god man och boende ombesörjandes inte i god tid. Barnens integrationsprocess påverkades negativt och osäkerhet kring asylprocessens orsakade psykisk ohälsa hos ensamkommande barnen. Socialtjänstens ansvarsutövning angående ensamkommande barnens integration och empowerment var således bristfällig i början som förbättrades under senare åren. Slutsats: Socialsekreterarna kunde inte följa sina riktlinjer utifrån socialtjänstlagen under hösten 2015. De var tvungna att prioritera barnens basala behov såsom boende och ekonomiskt stöd över integrationsprocessen under en lång och stressig period då det saknades boende, skola med mera. Det blev dock bättre senare när kommunen anställde fler socialsekreterare, tolk och god man. / Background: Statistics shows that 35 369 unaccompanied children applied for asylum in Sweden in 2015. It was a dramatic increase in number of asylum seekers as compared to the previous years and the following years. There were insufficiencies in performance of Social Services regarding unaccompanied children in previous years under normal circumstances. We wanted to study if the Social services were able to meet the basic needs and rights of the unaccompanied children in accordance with the Social Services Act and the UN’s Children’s Convention after the huge influx of asylum seekers in Sweden in a short span of time in 2015. Objective: The purpose of our research was to study the experiences of personnel of The Social Services about their performance of their duty regarding integration and empowerment of unaccompanied children who have come to Sweden in 2015 and onwards. Our question formulation was: How have the personnel of the social services performed their duties regarding integration of unaccompanied children who have come to Sweden in 2015 and onwards? Method: Qualitative method was chosen for this study in which we formulated a questionnaire consisting of 20 semi-structured questions and interviewed a group of nine experienced social workers in Gothenburg region. The interviews were done digitally or by telephone due to Corona pandemic. All the interviews were recorded and then transcribed. Results: The respondents had experienced the situation in 2015 as “stressful”, “very tough”, “chaotic” and “overwhelming” as neither the counties nor the society at large was ready for such a huge influx of refugees. As a consequence, the basic needs of the unaccompanied children were not fulfilled, such as right to shelter, and allocation of case officers and legal guardians were delayed. It had a negative effect on the children’s integration process and uncertainty about their asylum process had caused psychiatric illness. Conclusion: The social workers could not follow their guidelines of in accordance with The Social Services Act in 2015. They were instead forced to prioritize the basic needs of the children, such accommodation, daily expenses and school over integration and empowerment. It got better, however, as the situations improved later on as the counties had employed more social workers, interpreters and legal guardians.

Reservoir testing and analysis are fundamental tools in understanding reservoir hydraulics and hence forecasting reservoir responses. The quality of the analysis is very dependent on the conceptual model used in investigating the responses under different flowing conditions. The use of reservoir testing in the characterization and derivation of reservoir parameters is widely established, especially in conventional oil and gas reservoirs. However, with depleting conventional reserves, the quest for unconventional reservoirs to secure the increasing demand for energy is increasing; which has triggered intensive research in the fields of reservoir characterization. Gas hydrate reservoirs, being one of the unconventional gas reservoirs with huge energy potential, is still in the juvenile stage with reservoir testing as compared to the other unconventional reservoirs. The endothermic dissociation hydrates to gas and water requires addressing multiphase flow and heat energy balance, which has made efforts to develop reservoir testing models in this field difficult. As of now, analytically quantifying the effect on hydrate dissociation on rate and pressure transient responses are till date a huge challenge. During depressurization, the heat energy stored in the reservoir is used up and due to the endothermic nature of the dissociation; heat flux begins from the confining layers. For Class 3 gas hydrates, just heat conduction would be responsible for the heat influx and further hydrate dissociation; however, the moving boundary problem could also be an issue to address in this reservoir, depending on the equilibrium pressure. To address heat flux problem, a proper definition of the inner boundary condition for temperature propagation using a Clausius-Clapeyron type hydrate equilibrium model is required. In Class 1 and 2, crossflow problems would occur and depending on the layer of production, convective heat influx from the free fluid layer and heat conduction from the cap rock of the hydrate layer would be further issues to address. All these phenomena make the derivation of a suitable reservoir testing model very complex. However, with a strong combination of heat energy and mass balance techniques, a representative diffusivity equation can be derived. Reservoir testing models have been developed and responses investigated for different boundary conditions in normally pressured Class 3 gas hydrates, over-pressured Class 3 gas hydrates (moving boundary problem) and Class 1 and 2 gas hydrates (crossflow problem). The effects of heat flux on the reservoir responses have been addressed in detail.

Reservoir testing and analysis are fundamental tools in understanding reservoir hydraulics and hence forecasting reservoir responses. The quality of the analysis is very dependent on the conceptual model used in investigating the responses under different flowing conditions. The use of reservoir testing in the characterization and derivation of reservoir parameters is widely established, especially in conventional oil and gas reservoirs. However, with depleting conventional reserves, the quest for unconventional reservoirs to secure the increasing demand for energy is increasing; which has triggered intensive research in the fields of reservoir characterization. Gas hydrate reservoirs, being one of the unconventional gas reservoirs with huge energy potential, is still in the juvenile stage with reservoir testing as compared to the other unconventional reservoirs. The endothermic dissociation hydrates to gas and water requires addressing multiphase flow and heat energy balance, which has made efforts to develop reservoir testing models in this field difficult. As of now, analytically quantifying the effect on hydrate dissociation on rate and pressure transient responses are till date a huge challenge. During depressurization, the heat energy stored in the reservoir is used up and due to the endothermic nature of the dissociation; heat flux begins from the confining layers. For Class 3 gas hydrates, just heat conduction would be responsible for the heat influx and further hydrate dissociation; however, the moving boundary problem could also be an issue to address in this reservoir, depending on the equilibrium pressure. To address heat flux problem, a proper definition of the inner boundary condition for temperature propagation using a Clausius-Clapeyron type hydrate equilibrium model is required. In Class 1 and 2, crossflow problems would occur and depending on the layer of production, convective heat influx from the free fluid layer and heat conduction from the cap rock of the hydrate layer would be further issues to address. All these phenomena make the derivation of a suitable reservoir testing model very complex. However, with a strong combination of heat energy and mass balance techniques, a representative diffusivity equation can be derived. Reservoir testing models have been developed and responses investigated for different boundary conditions in normally pressured Class 3 gas hydrates, over-pressured Class 3 gas hydrates (moving boundary problem) and Class 1 and 2 gas hydrates (crossflow problem). The effects of heat flux on the reservoir responses have been addressed in detail.

Les polynucléaires neutrophiles représentent 50-70% des leucocytes sanguins et possèdent un rôle majeur dans la défense de l’organisme contre les pathogènes. Le Ca2+ est un second messager qui joue un rôle primordial dans le chimiotactisme, la phagocytose, la dégranulation et la production de formes réactives de l’oxygène (FRO) afin de neutraliser l’agent pathogène. Dans ces cellules, l’influx calcique de type SOCE est essentiel pour l'homéostasie calcique. Il est peu étudié en raison du manque d’outils pharmacologiques spécifiques d’où l’importance dans un premier temps de chercher de nouvelles molécules. Les cellules T Jurkat dont le SOCE est largement caractérisé servent de modèle pour la caractérisation initiale de ces molécules. Le 2-APB est parmi les molécules les plus largement utilisées dans la caractérisation du SOCE en raison de sa double activité sur le SOCE avec une potentialisation à [1-10 μM] et une inhibition à [> 20 μM]. En revanche, ce produit manque de spécificité et agit sur d’autres cibles cellulaires comme les récepteurs à l’inositol (1,4,5)-trisphosphate (InsP3Rs). La 1ère étape est de sélectionner à partir d’analogues commerciaux du 2-APB (Methoxy-APB, Dimethoxy-APB, Cyclic-APB, Benzothienyl-APB, Thienyl-APB et MDEB), des composés plus spécifiques et également plus efficaces que la molécule mère. Deux molécules se sont distinguées : le MDEB comme uniquement potentialisant du SOCE et le Benzothienyl-APB comme un puissant inhibiteur. En revanche, tous les analogues du 2-APB inhibent les InsP3Rs à l’exception du MDEB qui semble plus spécifique du SOCE. L’effet du MDEB sur le courant calcique, ICRAC, a été étudié grâce à la technique du patch-clamp. Il augmente d’environ 4 fois l’amplitude de ICRAC par rapport à celle enregistrée dans les cellules contrôle. Par ailleurs, le MDEB ralentie l’inactivation rapide de ICRAC due au Ca2+. Sur le plan physiologique, le MDEB à des concentrations croissantes inhibe la synthèse de l’IL-2 dans les cellules Jurkat stimulées et ceci malgré son effet potentialisant du SOCE. Cette activité est liée à son effet pro-apoptotique dans les cellules Jurkat stimulées. Le MDEB et le Benzothienyl-APB caractérisés dans la 1ère partie nous ont servi d’outils potentiels afin d’étudier le SOCE des cellules PLB-985 différenciées en cellules proches de neutrophiles. Le SOCE a été induit soit par un traitement des cellules avec la thapsigargine (Tg) soit de manière physiologique avec les peptides fMLF et le WKYMVm deux chimioattractants, ligands des récepteurs aux peptides formylés FPR et FPRL1 respectivement. En plus, le SOCE induit par la Tg est modulable par le 2-APB, potentialisé par le MDEB et inhibé par le Benzothienyl-APB. La phagocytose des levures par les cellules PLB-985 différenciées ainsi que la production de FRO intraphagosomales ont été inhibées par le MDEB et le Benzothienyl-APB. Les FRO extracellulaires ont été également inhibées par Benzothienyl-APB en revanche à cause de la forte interférence du MDEB avec la technique de mesure nous n’avons pas pu étudier ses activités. En conclusion, le MDEB et le Benzothienyl-APB sont de nouveaux outils pharmacologiques potentialisant ou inhibant le SOCE des leucocytes, qui nous permettront dans l’avenir une meilleure compréhension de l'entrée calcique et ses rôles dans ces cellules. / Neutrophils represent 50-70% of human blood leukocytes; their role is to protect the body against pathogens. Calcium is a second messenger which plays an important role in chemotaxis, phagocytosis, degranulation and the production of reactive oxygen species (ROS) in order to eliminate microbes. In neutrophils, the mechanism of store-operated calcium entry (SOCE) is essential for calcium homeostasis. However, neutrophil SOCE is not well understood because of the lack of specific pharmacological tools. It is necessary to first identify and characterize new molecules using a model of Jurkat T cells in which SOCE was the best characterized. 2-APB is the most widely used molecule in SOCE characterization due to its dual activity with a potentiation at lower concentrations [1-10 μM] and an inhibition at higher concentrations [> 20 μM]. However, this molecule lacks specificity because it acts on other cellular targets such as inositol (1,4,5)-trisphosphate receptors (InsP3Rs). The first step is to select from a library of 8 commercial 2-APB analogues (Methoxy-APB, Dimethoxy-APB, Cyclic-APB, Benzothienyl-APB, Thienyl-APB and MDEB) those that are more specific and also more efficient molecules than 2-APB. Two interesting molecules were identified, MDEB as the only SOCE potentiating product currently known and the Benzothienyl-APB, which is a strong inhibitor. Like 2-APB, all these analogues inhibit InsP3Rs except MDEB, which seems to be more specific. The effect of MDEB on the calcium current, ICRAC, was also studied using the patch-clamp technique. MDEB increases ~4 times the ICRAC amplitude in comparison with control. Otherwise, MDEB slows down the fast Ca2 +-dependent inactivation of ICRAC. Functionally, MDEB at increasing concentrations inhibits IL-2 synthesis in stimulated Jurkat T cells despite its potentiating activity on SOCE. The inhibition is due to MDEB induced apoptosis in stimulated Jurkat T cells. MDEB and Benzothienyl-APB were then used as tools to study SOCE in a neutrophil-like cell model, the differentiated PLB-985 cells. SOCE was induced either by treatment of cells with thapsigargin (Tg) or physiologically with the chemotactic peptides fMLF and WKYMVm, ligands of formyl peptide receptors FPR and FPRL1 respectively. In addition, Tg-induced SOCE was modulated by 2-APB, potentiated by MDEB and inhibited by Benzothienyl-APB. The consequences of these analogues on neutrophil functions were also studied. Phagocytosis of yeasts by PLB-985 cells and intraphagosomal ROS production were inhibited by MDEB and Benzothienyl-APB. Furthermore, extracellular ROS were also inhibited by Benzothienyl-APB. However, because of the high interference of MDEB with our techniques, its activities could not be studied. In conclusion, MDEB and Benzothienyl-APB are new analogues of 2-APB potentiating and inhibiting SOCE, which allow us in the future a better understanding of leukocyte SOCE and its cellular roles.

Multiple Sklerose (MS) ist eine heterogene Krankheit des Zentralnervensystems, deren pathologische Mechanismen noch nicht vollständig aufgeklärt sind. Die gegenwärtige Hypothese ist, daß pro-inflammatorische T-Zellen entscheidend an der Pathogenese der MS beteiligt sind. Man geht davon aus, daß eine Fehlregulation der T-Zell-Kontrolle, möglicherweise bedingt durch ein Ungleichgewicht an Apoptose-regulierenden Molekülen, dabei eine Rolle spielt. Tatsächlich zielen therapeutische Strategien darauf ab, T-Zell-Aktivierung, Proliferation und Produktion von Zytokinen zu verringern, oder T-Zell-Eliminierung zu fördern. Diese Arbeit sollte zum einen die Bedeutung regulatorischer Faktoren klären, die für das überleben der T-Zellen von MS-Patienten verantwortlich sind. Zum anderen sollten die antiproliferative oder Apoptose-fördende Wirkung potentiell therapeutisch wirksamer Moleküle untersucht werden. Eine eingeschränkte Regulation der autoreaktiven T-Zellen durch Apoptose in der Peripherie und im ZNS trägt möglicherweise zur Pathophysiologie der MS bei. Als Schlüsselfaktoren der Regulation von Apoptose wurden Mitglieder der Bcl-2-Familie in MS-Patienten und Probanden untersucht. Diese Faktoren wurden in Relation zu der Suszeptibilität der T-Zellen gegenüber aktivierungsinduziertem Zelltod (sog. Activation-induced cell death oder AICD) überprüft. Um die in-vivo-Elimination der Antigen-reaktiven T-Zellen nachzuahmen, wurde ein in-vitro-Modell des AICD mit repetitiver T-Zell-Stimulation verwendet. Tatsächlich zeigten polyklonale T-Zellen von MS-Patienten eine verringerte Suszeptibilität für AICD, nachgewiesen sowohl durch verminderte Caspaseaktivtät (p=0.013) als auch durch DNA-Fragmentierung (p=0.0071). Weiter wurden höhere Spiegel des Proteins Bcl-XL in den Immunzellen von MS-Patienten mit Immunoblotting gemessen (p=0.014). Eine inverse Korrelation zwischen der Expression an Bcl-XL und der Empfindlichkeit der T-Zellen gegenüber AICD steht in Übereinstimmung mit vorhergehenden Daten bezüglich der Bedeutung dieses Proteins für die Apoptose-Resistenz von T-Zellen. Es wurde bereits gezeigt, daß dieses Molekül die Ausprägung der experimentell-autoimmun Enzephalomyelitis, des Tiermodells der MS, verstärkt. Zusammen mit den erhöhten Bcl-XL-Werten bei MS-Patienten, ergeben sich nun Perspektiven für einen therapeutischen Ansatz. Abgesehen von dem Konzept die apoptotische Eliminierung von T-Zellen zu unterstützen, streben gegenwärtige therapeutische Strategien an, die Aktivierung und weitere Proliferation der schädlichen T-Zellen zu hemmen. Basierend auf klinischer Erfahrung mit eher unselektiven Therapien, ist es ein therapeutisches Ziel, neue immunomodulatorische Substanzen mit besserer Selektivität zu finden, um das Nutzen/Risiko-Verhältnis zu maximieren. Aus diesem Grund wurden zwei unterschiedliche Substanzen untersucht die beide den Zellzyklus beeinflussen. Als erster Kandidat wurde der kürzlich entdeckte Todesligand TRAIL (engl.: TNF-related apoptosis inducing ligand) aus der TNF/NGF-Familie untersucht, da diesem bereits T-Zell-regulatorische Funktionen zugeschrieben worden waren, humane Antigen-spezifische T-Zellen jedoch resistent gegenüber TRAIL-induzierter Apoptose sind. Der zweite Kandidat mit potenziell therapeutischer Wirkung bei MS ist Atorvastatin, ein HMG-CoA-Reduktase-Hemmer, der bereits als Lipidsenker bei Patienten eingesetzt wird. Um die Hypothese zu überprüfen, daß diese Substanzen T-Zell-Rezeptor-Signale beeinflussen können, wurden humane Antigen-spezifische T-Zell-Linien von MS-Patienten und gesunden Probanden eingesetzt. Diese wurden hinsichtlich T-Helfer-Phänotyp und Peptid-Spezifität charakterisiert. Eine Behandlung mit TRAIL führte zur Hemmung der Proliferation in unterschiedlichem Ausmaß (6.2% - 63.8%). Atorvastatin hemmte in Abhängigkeit von der Dosis ebenso die Proliferation Antigen-spezifischer T-Zellen. Beide Substanzen wirkten antiproliferativ unabhängig von der Antigenpräsentation, aufgrund ihrer Fähigkeit, die Proliferation in Abwesenheit von professionellen Antigen-präsentierenden Zellen zu vermindern. Diese Eigenschaft weißt auf einen direkten Einfluß auf die T-Zell-Funktion hin. Die TRAIL-induzierte Hypoproliferation war assoziiert mit einer Herunterregulation der Zyklin-abhängigen Kinase CDK4 (engl.: cyclin dependent kinase 4), einem Schlüsselenzym für die nach T-Zell-Rezeptor-Stimulation einsetzende Transition von der G1- zur S-Phase des Zellzyklus. Inkubation mit Atorvastatin induzierte ebenso eine Verminderung von CDK4, begleitet von einer Erhöhung von p27Kip1. Die Atorvastatin-vermittelte Proliferations- und Zellzyklus-Blockade konnte durch Mevalonat rückgängig gemacht werden. Mevalonat ist ein Zwischenprodukt des HMG-CoA-Reduktaseweges. Atorvastatin scheint demnach einen direkten Einfluß auf diese Enzymkaskade zu haben, der wichtig für die Isoprenylierung von GTPase-Proteinen der Rho-Familie ist. T-Zell-Rezeptor-Stimulation führt zur Freisetzung von Kalzium aus intrazellulären Speichern und nachfolgend zur Öffnung transmembranöser Kalzium-Kanäle (sog. calcium release-activated calcium oder CRAC-Kanäle), die eine für die T-Zellaktivierung notwendige und anhaltende Erhöhung der intrazellulären Kalzium-Konzentration hervorruft. Nach Behandlung mit TRAIL wurde eine konzentrationsabhängige Inhibition des Einstroms extrazellulärer Kalzium-Ionen durch die CRAC-Kanäle beobachtet. Dies wurde mit löslichem TRAIL-Rezeptor-Fusionsprotein, einem TRAIL-Antagonisten, rückgängig gemacht. Die Blockade von Kalzium-abhängigen Aktivierungssignalen stellt damit möglicherweise einen primären immunregulatorischen Mechanismus für diese Todesliganden dar. Jedoch wurde keine Auswirkung von Atorvastatin auf die T-Zellaktivierung beobachtet, da der Einstrom von extrazellulärem Kalzium nicht beeinflußt wurde. Während Studien zum TRAIL-vermittelten Einfluß auf die T-Zell-Aktivierung und dem Zellzyklus erst in der präklinischen Phase sind, werden Statine, die ebenfalls den Zellzyklus beeinflussen, bereits in der Therapie anderer Erkrankungen angewand. Darüber hinaus werden derzeit bereits klinische Studien mit Statinen zur MS-Therapie durchgeführt. Weitere Untersuchungen zu den detaillierten Mechanismen antiproliferativer Substanzen mit potenziellem therapeutischen Effekt in der MS ermöglichen die Entwicklung von selektiveren immunomodulatorischen Therapien mit höherem therapeutischen Nutzen für MS-Patienten. / Multiple sclerosis (MS) is a heterogeneous disease of the central nervous system whose pathological mechanisms are far from completely understood. The current hypothesis is that pro-inflammatory T cells are orchestrating the pathogenesis of this condition. It is considered that a dysregulation in T cell control to be involved, with an imbalance in apoptosis-regulating molecules possibly playing a role. In fact, therapeutic strategies aim to reduce T cell activation, proliferation and cytokine production or to promote T cell elimination. The focus of this thesis was to identify the role of regulatory molecules for T cell survival in the immune pathogenesis of MS, and to investigate antiproliferative or apoptosis-promoting effects on T cells by potential therapeutic molecules. A limitation in the apoptotic regulation of autoreactive T cells in the periphery and in the CNS may contribute to the pathophysiology of MS. As key regulators of apoptosis, members of the Bcl-2 family were investigated in both MS patients and controls. These factors were examined in relation to the susceptibility of T cells, from both groups, towards activation-induced cell death (AICD). To mimic the in vivo elimination of antigen-reactive T cells, an in vitro model of AICD involving repetitive T cell receptor mediated stimulation was utilized. In fact, polyclonal T cells from MS patients showed a decreased susceptibility to undergo AICD as shown by both caspase activity (p=0.013) and DNA fragmentation (p=0.0071) assays. Furthermore, Bcl-XL protein levels, as measured by immunoblotting, were increased in the peripheral immune cells of MS patients (p=0.014). An inverse correlation observed between Bcl-XL levels and susceptibility of T cells to undergo AICD is in line with previous data on the significance of this anti-apoptotic protein in T cell resistance. Since this molecule has already been shown to aggravate the outcome of experimental autoimmune encephalitis, the animal model for MS, the observation of elevated Bcl-XL levels in patients offers perspectives towards therapeutic manipulation in MS. Apart from promoting apoptotic elimination, current therapeutic strategies aim at inhibiting activation and further proliferation of potentially harmful T cells. Based on clinical experience with rather non-selective therapies that promote T cell elimination, a therapeutic goal is to identify newer immunomodulatory substances with better selectivity in order to maximize the therapy's benefit to risk ratio. Thus, two different substances, both interfering with cell cycle regulation, were investigated. The first candidate was the recently discovered member of the TNF/NGF family of death ligands, TNF-related apoptosis inducing ligand (TRAIL) since it has been reported to have immunoregulatory functions and since human antigen-specific T cells were shown to be resistant towards apoptosis induction by this ligand. The second candidate drug with potential in MS therapy is atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme (HMG-CoA) reductase inhibitor and lipid-lowering drug, already indicated for anomalies in lipid metabolism. In order to prove the hypothesis that these substances interfere with T cell receptor signaling, human antigen-specific T cell lines from both MS patients and controls, characterized with regards to T helper differentiation and peptide specificity, were employed. Exogenous treatment of TRAIL resulted in an inhibition in proliferation, albeit to varying degrees (6.2% - 63.8% inhibition). Atorvastatin also inhibited proliferation of antigen-specific T cell lines in a dose-dependent manner. Both compounds induced hypoproliferation independently of antigen presentation, as shown by their ability to block T cell proliferation in response to direct T cell receptor engagement, thus indicating a direct influence on T cell function. The growth inhibition by TRAIL was associated with a downregulation of the cell cycle regulator CDK4, indicative of an inhibition of cell cycle progression at the G1/S transition. Incubating T cells with atorvastatin also induced a downregulation of CDK4 expression, which was accompanied by an upregulation of p27Kip1 expression. The atorvastatin-mediated inhibition in proliferation and cell cycle progression could be reversed by mevalonate, an intermediate product of the HMG-CoA reductase pathway, suggesting a direct involvement of atorvastatin in this pathway, necessary for the isoprenylation of small GTPase proteins of the Rho family. Utilizing a thapsigargin model of calcium influx to activate the same calcium-release activated calcium (CRAC) channels as T cell receptor-stimulation by antigen, an inhibition in calcium influx could be observed on pre-incubating T cells with TRAIL. Co-incubating with human recombinant TRAIL receptor 2 fusion protein, a competitive antagonist for TRAIL, reversed this inhibition. A direct influence on calcium influx is indicative of an influence of TRAIL on the activation status of human T cells. Therefore, TRAIL directly inhibits activation of these cells via blockade of calcium influx. However, no impact of atorvastatin on early T cell activation was observed, since calcium influx was unaffected. While TRAIL-mediated interference with T cell activation and further cell cycle progression is still in the pre-clinical phase, statins, which have also been shown here to interfere with the T cell cycle, are already employed in the clinic for other ailments. In fact, clinical trials are currently being undertaken with this group of drugs for MS. Further studies on detailed mechanisms of antiproliferative substances effective in MS will allow the development of highly selective immunomodulatory agents with increased beneficial profile as MS therapy.